PEAChY-O:儿童与青少年激越的紧急药物管理:口服药物随机对照试验
PEAChY-O为开放标签、多中心随机对照试验,2021年10月22日至2023年11月6日在9个澳大利亚急诊科纳入9–17岁急性严重行为障碍、需口服药物的青少年,随机给予单次按体重计算的口服奥氮平或口服地西泮。主要终点为随机化后1小时达到成功镇静(Sedation Assessment Tool评分≤0)且无需追加镇静剂。348例中奥氮平组176例、地西泮组172例,成功镇静分别为103/168(61%)与90/158(57%),校正风险差3.6%(95%CI -6.7%至14.0%)。两组均无严重不良事件,但每组约40%未达到成功镇静。
要点
- 9–17岁急性严重行为障碍需口服药物的青少年中,口服奥氮平组1小时成功镇静103/168(61%),口服地西泮组90/158(57%),校正风险差3.6%(95%CI -6.7%至14.0%),无显著差异。
- 两组均未报告严重不良事件。
- 每组约40%的参与者在随机化后1小时未达到成功镇静(奥氮平组65/168,地西泮组68/158)。
- 主要终点为随机化后1小时Sedation Assessment Tool评分≤0且无需追加镇静剂。
适用人群与场景
- 9–17岁、因急性严重行为障碍到急诊就诊、被判定需要口服药物的青少年;来自9个澳大利亚急诊科。
诊断标准与关键阈值
- 成功镇静定义为随机化后1小时Sedation Assessment Tool评分≤0且无需追加镇静剂。
处置流程与药物剂量
- 随机给予单次按体重计算的口服奥氮平或口服地西泮;具体剂量、给药频次与疗程原文未写明。
研究设计与关键结果
- 开放标签、多中心随机对照试验,2021年10月22日至2023年11月6日,9个澳大利亚急诊科,纳入348例9–17岁急性严重行为障碍青少年,奥氮平组176例、地西泮组172例。
- 主要终点:随机化后1小时成功镇静且无需追加镇静剂,奥氮平组103/168(61%)vs 地西泮组90/158(57%),校正风险差3.6%(95%CI -6.7%至14.0%)。
- 两组均未报告严重不良事件。
- 每组约40%的参与者未达到成功镇静(奥氮平组65/168,地西泮组68/158)。
- 次要终点包括不良事件、住院时间、对工作人员/参与者/父母或监护人的攻击行为、去向及对护理的满意度;原文未报告这些次要终点的具体结果。
证据类型、等级与局限
- 证据类型:开放标签、多中心随机对照试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于9–17岁急性严重行为障碍、需口服药物的青少年,口服奥氮平与口服地西泮在1小时成功镇静率上无显著差异,两组均无严重不良事件,但每组约40%未达到成功镇静。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
STUDY OBJECTIVE: To determine whether oral olanzapine or oral diazepam was more effective at achieving behavioral containment for young people presenting to the emergency department with acute severe behavioral disturbance.
METHODS: We conducted an open-label, multicenter, randomized controlled trial from October 22, 2021, to November 6, 2023. We enrolled young people aged between 9 and 17 years with acute severe behavioral disturbance deemed to require oral medication across 9 Australian emergency departments. We randomly assigned participants to a single weight-based oral dose of olanzapine or diazepam. The primary outcome was successful sedation (Sedation Assessment Tool score less than or equal to 0) without the need for additional sedatives one hour postrandomization. Secondary outcomes included adverse events; length of stay; aggression toward staff, participants, or parent/guardians; disposition; and satisfaction with care.
RESULTS: We recruited 348 participants, with 176 assigned to olanzapine and 172 to diazepam. Successful sedation without the requirement for additional sedatives occurred in 103/168 (61%) in the olanzapine group and 90/158 (57%) in the diazepam group (adjusted risk difference 3.6%, 95% confidence interval -6.7% to 14.0%). No serious adverse events were reported in either group.
CONCLUSIONS: There was no evidence that oral olanzapine resulted in a greater proportion of participants with acute severe behavioral disturbance achieving successful sedation at one hour postrandomization than oral diazepam. Neither medication resulted in any serious adverse events; however, approximately 40% of participants in each group did not achieve successful sedation.
参考来源
- Bourke EM, Kochar A, Shellshear D, et al. PEAChY-O: Pharmacological Emergency Management of Agitation in Children and Young People: A Randomized Controlled Trial of Oral Medication. Ann Emerg Med. 2025. PMID: 39955661. doi:10.1016/j.annemergmed.2025.01.007
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。